Research proves UltraSPECT claims for quick scansTraxtal prepares to launch navigational upgrade at SIR 2009Ziehm releases C-arm in Europe
The latest product from UltraSPECT can cut data acquisition during cardiac SPECT perfusion exams to a quarter of the time traditionally required yet still provide diagnostic images, according to research conducted at St. Luke's-Roosevelt Hospital in New York City. The Xpress3.Cardiac allows cardiac acquisitions in as little as three minutes, according to Dr. E. Gordon DePuey, director of nuclear medicine at St. Luke's-Roosevelt. Lengthening the acquisition time allows the administration of lower dose, DePuey said. The software is the most recent release in the Xpress family. The first, commercialized four years ago, cut SPECT acquisition time by half.
A smaller, lighter, more ergonomic navigational system for interventional radiology will debut March 7 in the Traxtal booth during the Society of Interventional Radiology meeting in San Diego. The cornerstone of the PercuNav upgrade is a newly designed system cart. An integrated control panel with optimized interface and dedicated pushbutton functions allows easier operation of the system, which reconstructs and fuses CT, MR, ultrasound, and PET data to guide interventions.
A new intraoperative C-arm system from Ziehm Imaging is on the European market. The Ziehm Vision RFD integrates a flat-panel detector with a mobile imaging platform designed for interventional radiology, neurosurgery, vascular surgery, and cardiology. The digital imaging chain supports expanded dynamic range, which allows the visualization of detailed soft tissue, contrast-filled vessels, and bony anatomy in the same image.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.